Medical Device News Magazine

Osteo-Site Vertebral Balloon and Complex VCF Treatment Toolbox Launches

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Osteo-Site Vertebral Balloon for vertebral augmentation has launched. The news was announced today by IZI Medical Products, a manufacturer of interventional radiology devices.

Osteo-Site Vertebral Balloon completes IZI’s offering of Vertebral Compression Fracture (“VCF”) treatment options, which include Osteo-Site Vertebroplasty, Osteo-Site Balloon Kyphoplasty, Blazer Curved Needle Augmentation, and Kiva PEEK Implant-based augmentation.

“We want to enable our physicians to choose the most clinically appropriate solution for their patients when treating vertebral compression fractures,” said Greg Groenke, CEO, IZI Medical. “We have created an integrated portfolio of VCF treatment devices with the ability to switch between different treatment options with ease.”

“IZI has completed the VCF toolbox: Kiva for metastatic VCF’s, Blazer Curved Needle for targeted cement deployment in sclerotic bone and blastic metastases, and now Osteo-site Balloon and curved needle for osteoporotic fractures. IZI has made it simple to switch between all of them which gives me intra-operative flexibility,” said Dr. Kieran Murphy, Professor of Radiology at University Health Network Toronto.

The new Osteo-site Vertebral Balloon is designed to create a cavity within the vertebral body. Currently, the balloon is available in 10G and 11G sizes. “The Osteo-site balloon will be paired with our Duro-Ject Injector, which provides maximum control and feedback during injection and minimizes radiation exposure with a long flexible tubing,” said Jovie Soriano, SVP Marketing and Business Development, IZI Medical. “We have also made improvements to our Murphy access needles based on physician feedback that will be included in the Osteo-Site Balloon kit.”

IZI Medical’s VCF portfolio will be supported by a dedicated sales team of direct representatives and independent distributors to drive market penetration in the United States, followed by expansion into Europe.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.